IRICoR is a not-for-profit drug discovery and commercialization centre based at the Institute for Research in Immunology and Cancer (IRIC) on the Université de Montréal campus.
Our main objective is to rapidly translate highly innovative scientific projects into high value novel therapies in oncology, immunology, and related indications through strong partnerships with the private sector — thereby efficiently bridging the innovation translation gap between early stage academic research and industry.
Company Details
- Employees
- 11
- Founded
- -
- Address
- 2950 Chemin De Polytechnique, Montreal,quebec H3c 3j7,canada
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.iricor.ca
- Keywords
- Drug discovery, Drug development, Licensing, Partnerships, Commercialization, Medicinal chemistry, Immunology and cancer research.
- HQ
- Montreal, Quebec
Iricor Questions
Iricor's website is http://www.iricor.ca
Iricor's LinkedIn profile is https://ca.linkedin.com/company/iricor
Iricor has
11 employees.
View email and phone details for 11
employees at Iricor.
Iricor's industry is
Biotechnology Research
Iricor's categories are Biotechnology Research
Iricor's founding year is 2008
